BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Senzolo M, Garcia-Tsao G, García-Pagán JC. Current knowledge and management of portal vein thrombosis in cirrhosis. J Hepatol 2021;75:442-53. [PMID: 33930474 DOI: 10.1016/j.jhep.2021.04.029] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Zanetto A, Campello E, Bulato C, Gavasso S, Farinati F, Russo FP, Tormene D, Burra P, Senzolo M, Simioni P. Increased platelet aggregation in patients with decompensated cirrhosis indicates higher risk of further decompensation and death. Journal of Hepatology 2022. [DOI: 10.1016/j.jhep.2022.03.009] [Reference Citation Analysis]
2 Roberts LN. Rebalanced hemostasis in liver disease: a misunderstood coagulopathy. Hematology Am Soc Hematol Educ Program 2021;2021:485-91. [PMID: 34889414 DOI: 10.1182/hematology.2021000283] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Ginès P, Krag A, Abraldes JG, Solà E, Fabrellas N, Kamath PS. Liver cirrhosis. Lancet 2021;398:1359-76. [PMID: 34543610 DOI: 10.1016/S0140-6736(21)01374-X] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
4 Zanetto A, Campello E, Bulato C, Gavasso S, Saggiorato G, Shalaby S, Spiezia L, Cillo U, Farinati F, Russo FP, Burra P, Senzolo M, Simioni P. More Pronounced Hypercoagulable State and Hypofibrinolysis in Patients With Cirrhosis With Versus Without HCC. Hepatol Commun 2021;5:1987-2000. [PMID: 34558850 DOI: 10.1002/hep4.1781] [Reference Citation Analysis]
5 Xing Y, Jiang Y, Xing S, Mao T, Guan G, Niu Q, Zhao X, Zhou J, Jing X. Neutrophil extracellular traps are associated with enhanced procoagulant activity in liver cirrhosis patients with portal vein thrombosis. J Clin Lab Anal 2022;:e24433. [PMID: 35435260 DOI: 10.1002/jcla.24433] [Reference Citation Analysis]
6 Oliveira CAM, Trevizoli NC, Romeres SGB, Obeid EJ, Paludetto G, Ferreira GSA, De Campos PB, Ullmann RFB, Rocha HC, Figueira AVF, Diaz LGG, Jorge FMF, Caja GON, Watanabe ALC. Liver Transplantation After Acute Portal Vein Thrombosis: Case Report. Transplant Proc 2022:S0041-1345(22)00269-X. [PMID: 35597672 DOI: 10.1016/j.transproceed.2022.04.004] [Reference Citation Analysis]
7 Faccia M, Santopaolo F, Gasbarrini A, Pompili M, Zocco MA, Ponziani FR. Risk factors for portal vein thrombosis or venous thromboembolism in a large cohort of hospitalized cirrhotic patients. Intern Emerg Med. [DOI: 10.1007/s11739-022-02928-8] [Reference Citation Analysis]
8 Li B, He Q, Lu G, Hong C, Chen J. Minor role of hemostatic alternation in portal vein thrombosis pathogenesis revealed by global measurement. J Hepatol 2021:S0168-8278(21)02031-6. [PMID: 34509525 DOI: 10.1016/j.jhep.2021.09.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Lisman T, Caldwell SH, Intagliata NM. Haemostatic alterations and management of haemostasis in patients with cirrhosis. J Hepatol 2022;76:1291-305. [PMID: 35589251 DOI: 10.1016/j.jhep.2021.11.004] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Ng CH, Tan DJH, Nistala KRY, Syn N, Xiao J, Tan EXX, Woo FZ, Chew NWS, Huang DQ, Dan YY, Sanyal AJ, Muthiah MD. A network meta-analysis of direct oral anticoagulants for portal vein thrombosis in cirrhosis. Hepatol Int 2021;15:1196-206. [PMID: 34417718 DOI: 10.1007/s12072-021-10247-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Xing Y, Tian Z, Jiang Y, Guan G, Niu Q, Sun X, Han R, Jing X. A practical nomogram based on systemic inflammatory markers for predicting portal vein thrombosis in patients with liver cirrhosis. Annals of Medicine 2022;54:302-9. [DOI: 10.1080/07853890.2022.2028893] [Reference Citation Analysis]